Global Expansion Sartorius Stedim Biotech has a global presence with manufacturing, sales, and R&D sites in over 20 countries. This expansive footprint opens up opportunities for international sales and partnerships with biopharma companies worldwide.

Recent Expansions Through recent investments in state-of-the-art facilities in Ann Arbor, Michigan, totaling $100 million, Sartorius is poised for growth in the U.S. market. Leveraging these newly expanded facilities can lead to increased sales and collaborations within the American biotechnology landscape.

Strategic Partnerships Collaborations with industry giants like Sanofi demonstrate Sartorius' commitment to innovation. Exclusive access to know-how and patents related to the ICB platform presents sales opportunities for cutting-edge solutions in bioprocessing, attracting potential clients seeking advanced technologies.

Product Launches The launch of Arium Mini Extend showcases Sartorius' continuous product innovation. Introducing new solutions to the market can attract customers looking for the latest advancements in biotech equipment, creating opportunities for sales growth and market expansion.

Market Recognition Being recognized as a leading partner in the biopharma industry signifies credibility and trust. Leveraging this reputation in sales pitches can help secure deals with stakeholders seeking reliable and reputable partners for their drug production needs.